| 发明名称 |
USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF DOGS |
| 摘要 |
The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs. |
| 申请公布号 |
US2016367562(A1) |
申请公布日期 |
2016.12.22 |
| 申请号 |
US201615251022 |
申请日期 |
2016.08.30 |
| 申请人 |
BOEHRINGER INGELHEIM VETMEDICA GMBH |
发明人 |
RUNDFELDT Chris;DOST Rita;LOSCHER Wolfgang;TIPOLD Andrea;UNVERFERTH Klaus;LANKAU Hans-Joachim |
| 分类号 |
A61K31/5377 |
主分类号 |
A61K31/5377 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
INGELHEIM DE |
